Medical Science News

RSS

Researchers discover how bacteria boost the immune system

Scientists have long known that certain types of bacteria boost the immune system. Now, Loyola University Health System researchers have discovered how bacteria perform this essential task.

15 Jun 2010

Entomologists to develop genetically engineered bacteria for killing mosquito larvae

Roughly half the world's population still lives in areas at risk of malaria transmission. Even in the United States, 1500 cases of malaria are reported annually on average.

15 Jun 2010

Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.

15 Jun 2010

CLC-5 protein plays active part in inherited kidney disorder: Scientists

Scientists from the University of Leeds have discovered the mechanisms of a protein known to play an active part in the inherited kidney disorder, Dent's disease. The findings provide a new focus for future therapies for the disease, for which there is currently no cure.

15 Jun 2010

New form of artificial human skin

Australian researchers are on the road to the discovery of a new form of artificial human skin that could be a boon to burn victims and other patients needing skin grafts. At present the available skin grafts are only 1 millimeter thick and serve only to replace the top epidermis layer.

14 Jun 2010

New Brunswick Scientific, Pall partner to develop new disposable bioreactor systems

New Brunswick Scientific, an Eppendorf Company, and Pall Corporation today announced a joint product development and marketing agreement to create and supply new disposable bioreactor systems.

From Pall Corporation 14 Jun 2010

Fluorescent cancerous tumors for early detection

Researchers at the Ecole Polytechnique F-d-rale de Lausanne (EPFL) in Switzerland have established a procedure where cancerous tumors in the bladder become fluorescent and are more easily discoverable under blue light. The Food and Drug Administration (FDA) approved the technique- already in practice in Europe - for the American market. Under the name Cysview-, the product is commercialized by Photocure and GE Healthcare as the most efficient detection technique for early stage bladder cancer.

14 Jun 2010

New path involving "innocent spectators" to defeat systemic sclerosis

There is a new path to defeat systemic sclerosis, also called scleroderma because of the hardening of the skin of the patients (from Greek skleros, "hard", and derma, "skin"). This path involves the B-cell of the immune system, so far only considered "innocent spectators," as Catholic University rheumatologist Gianfranco Ferraccioli, among the authors of the important research, puts it.

14 Jun 2010

BioScale secures $25 million for commercialization of ViBE protein analytics systems

BioScale Inc., a privately-held life science company that develops, manufactures and promotes a new generation of protein analytics technology, today announced that it has secured $25 million in its recent financing round. Led by new investor Morningside Venture, this round will be used to expand manufacturing operations and commercial sales of the ViBE protein analytics systems. Also participating in the financing were existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors

14 Jun 2010

Faron, Priaxon enter collaboration to develop new AOC3/SSAO antagonists

Faron Pharmaceuticals Ltd., Turku, Finland and Priaxon AG, Munich, Germany today announced the entry into a collaboration and commercialization agreement to obtain new superior AOC3/SSAO antagonists. This collaboration combines two world-class technologies, the thorough understanding of the AOC3-protein and its ligand interaction with the rapid discovery engine for the development of new chemical inhibitors of protein-protein interactions.

14 Jun 2010

DV Biologics executes agreement with System Biosciences to develop iPSC lines

DV Biologics LLC announced today that it has executed an agreement with System Biosciences LLC for the development of human-derived disease-specific induced pluripotent stem cell lines.

14 Jun 2010

Vitrolife enters into two year collaboration agreement with University of Melbourne

Vitrolife has entered into a two year collaboration agreement with University of Melbourne regarding collaboration with the stem cells expertise of the development of clinical grade stem cell media.

14 Jun 2010

Adolescent boys who attempt suicide more likely to be aggressive toward partners

Young men who attempt suicide before age 18 are much more likely as adults to be aggressive toward their girlfriends or wives, including hitting and injuring their partners, according to a new study.

14 Jun 2010

TF12 antibody targets EGP-1 expressed in epithelial cancer: Immunomedics

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.

14 Jun 2010

Researchers show how tiny insect brain uses multiple brain pathways to judge motion

Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.

14 Jun 2010

Dysfunctional magno cells in eyes associated with learning disabilities

Problems with math? And perhaps with handwriting - and motor skills? Researchers at the Norwegian University of Science and Technology (NTNU) believe that the explanation for your troubles may be that not all of the cells in your eyes work the way they should.

14 Jun 2010

New analysis contradicts study that brain consumes extra glucose when people exert self-control

Contradicting a popular model of self-control, a University of Pennsylvania psychologist says the data from a 2007 study argues against the idea that glucose is the resource used to manage self control and that humans rely on this energy source for will power.

14 Jun 2010

Monoclonal antibodies induce long-lasting, protective antiviral immune response

Monoclonal antibodies are the largest class of biotherapeutic drugs. When administered to infected organisms to blunt the propagation of pathogenic viruses, they may also induce a long-lasting and protective antiviral immune response similar to that achieved by vaccination. These results obtained in mice by the "Oncogenèse et Immunothérapie" group at the Institut de Génétique Moléculaire de Montpellier (CNRS/Universités Montpellier 1 and 2), have been published on 10 June in PLoS Pathogens.

14 Jun 2010

Astrocytes involved in regulation of signalling between neurons: Study

Astrocytes are the most common type of cell in the brain and play an important role in the function of neurons - nerve cells. New research from the University of Gothenburg, Sweden, shows that they are also directly involved in the regulation of signalling between neurons.

14 Jun 2010

Discarded livers have potential to be reengineered into usable replacement organs: Researchers

A team led by researchers from the Center for Engineering in Medicine at Massachusetts General Hospital has developed a technique that someday may allow growth of transplantable replacement livers. In their report that will be published in Nature Medicine and is receiving early online release, the investigators describe using the structural tissue of rat livers as scaffolding for the growth of tissue regenerated from liver cells introduced through a novel reseeding process.

14 Jun 2010

Medical Science News

Researchers discover how bacteria boost the immune system

Entomologists to develop genetically engineered bacteria for killing mosquito larvae

Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

CLC-5 protein plays active part in inherited kidney disorder: Scientists

New form of artificial human skin

New Brunswick Scientific, Pall partner to develop new disposable bioreactor systems

Fluorescent cancerous tumors for early detection

New path involving "innocent spectators" to defeat systemic sclerosis

BioScale secures $25 million for commercialization of ViBE protein analytics systems

Faron, Priaxon enter collaboration to develop new AOC3/SSAO antagonists

DV Biologics executes agreement with System Biosciences to develop iPSC lines

Vitrolife enters into two year collaboration agreement with University of Melbourne

Adolescent boys who attempt suicide more likely to be aggressive toward partners

TF12 antibody targets EGP-1 expressed in epithelial cancer: Immunomedics

Researchers show how tiny insect brain uses multiple brain pathways to judge motion

Dysfunctional magno cells in eyes associated with learning disabilities

New analysis contradicts study that brain consumes extra glucose when people exert self-control

Monoclonal antibodies induce long-lasting, protective antiviral immune response

Astrocytes involved in regulation of signalling between neurons: Study

Discarded livers have potential to be reengineered into usable replacement organs: Researchers

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News